Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VTS-270 in Niemann-Pick Type C1
NCT02534844Phase 3Completed
- Sponsor
- Mandos Health
- Start
- Oct 2015
- Primary completion
- Mar 2018
- Modality
- Nanoparticles, Small Molecules
- Countries
- 9
01
Overview
A Phase 3 trial of Trappsol Cyclo in Niemann-Pick disease type C1 (NPC1), sponsored by Mandos Health. Started Oct 2015; status: completed.
02
Drugs
Trappsol Cyclo
03
Conditions
Niemann-Pick disease type C1 (NPC1)
Beyond the preview
Go deeper on NCT02534844.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02534844.